Anavex Life Sciences Corp (AVXL)

[Boopka]

falconer, now let me throw you a curveball. We are in an election year plus we are talking about a drug potentially saving a country perhaps billions of dollars on health care costs. Coupled with that a well respected government agency friendly with the US, the TGA, that could share data going back 5-6 years now demonstrating both safety and efficacy for a high unmet disease featuring a low SOC. Is our FDA going to be so pompous as to not have high level discussions about 2-73? Will that at least get us to a fast track status or such?